Zenas BioPharma (ZBIO) Tax Provisions (2025 - 2026)

Zenas BioPharma (ZBIO) posted quarterly Tax Provisions of $106000.0 for Q4 2025, up 430.0% quarter-over-quarter from $20000.0 in Q2 2025.

Zenas BioPharma (ZBIO) Tax Provisions (2025 - 2026) Analysis & Trends

Zenas BioPharma's Tax Provisions history runs 1 years deep, the most recent figure standing at $106000.0 for Q4 2025.

In Q4 2025, Tax Provisions changed N/A year-over-year to $106000.0; the TTM figure through Dec 2025 stood at -$79000.0 (changed N/A YoY), while the FY2025 annual figure was -$79000.0, down 118.41% from the prior year.
Tax Provisions for Q4 2025 stood at $106000.0, up from $20000.0 in the prior quarter.
The five-year high for Tax Provisions was $106000.0 in Q4 2025, with the low at -$205000.0 in Q1 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Taxes (Qtr)
1	Vertex Pharmaceuticals	128.13 Bn	120.28 Bn	2.84 Bn	292.00 Mn
2	Regeneron Pharmaceuticals	112.33 Bn	104.33 Bn	3.93 Bn	230.90 Mn
3	Argenx Se	53.24 Bn	48.05 Bn	1.41 Bn	59.00 Mn
4	Revolution Medicines	43.64 Bn	43.64 Bn	-	-
5	BeOne Medicines	39.27 Bn	34.17 Bn	1.53 Bn	75.45 Mn
6	MindWalk Holdings	35.32 Bn	35.31 Bn	1.82 Bn	267.73
7	Royalty Pharma	33.72 Bn	35.84 Bn	-	-
8	Alnylam Pharmaceuticals	30.58 Bn	27.27 Bn	992.69 Mn	13.31 Mn
9	Insmed	27.01 Bn	25.85 Bn	358.27 Mn	1.90 Mn
10	Zenas BioPharma	1.87 Bn	748.44 Mn	-	114,000.00

Download Data